NasdaqGS - Nasdaq Real Time Price USD

Utah Medical Products, Inc. (UTMD)

Compare
64.57 +0.39 (+0.61%)
At close: November 21 at 4:00 PM EST
64.57 0.00 (0.00%)
After hours: November 21 at 4:00 PM EST
Loading Chart for UTMD
DELL
  • Previous Close 64.18
  • Open 64.20
  • Bid 46.22 x 200
  • Ask 82.79 x 100
  • Day's Range 63.96 - 64.57
  • 52 Week Range 63.38 - 87.21
  • Volume 15,907
  • Avg. Volume 20,904
  • Market Cap (intraday) 218.997M
  • Beta (5Y Monthly) 0.08
  • PE Ratio (TTM) 15.09
  • EPS (TTM) 4.28
  • Earnings Date Jan 28, 2025 - Feb 3, 2025
  • Forward Dividend & Yield 1.22 (1.90%)
  • Ex-Dividend Date Dec 16, 2024
  • 1y Target Est --

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO, an umbilical vessel catheters, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation devices; suprapubic catheterization; LIBERTY, an urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

www.utahmed.com

169

Full Time Employees

December 31

Fiscal Year Ends

Recent News: UTMD

View More

Performance Overview: UTMD

Trailing total returns as of 11/21/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

UTMD
22.32%
S&P 500
24.72%

1-Year Return

UTMD
21.77%
S&P 500
30.82%

3-Year Return

UTMD
40.83%
S&P 500
26.62%

5-Year Return

UTMD
31.77%
S&P 500
91.37%

Compare To: UTMD

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: UTMD

View More

Valuation Measures

Annual
As of 11/20/2024
  • Market Cap

    217.67M

  • Enterprise Value

    129.52M

  • Trailing P/E

    15.00

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.19

  • Price/Book (mrq)

    1.75

  • Enterprise Value/Revenue

    2.94

  • Enterprise Value/EBITDA

    7.29

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    34.62%

  • Return on Assets (ttm)

    8.18%

  • Return on Equity (ttm)

    12.31%

  • Revenue (ttm)

    44.08M

  • Net Income Avi to Common (ttm)

    15.26M

  • Diluted EPS (ttm)

    4.28

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    88.45M

  • Total Debt/Equity (mrq)

    0.24%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: UTMD

View More

Company Insights: UTMD

Research Reports: UTMD

View More

People Also Watch